Steven Kanner, Chief Scientific Officer at Caribou Biosciences, Inc. (CRBU), sold 3,564 shares at $1.35 ($5K) on 2025-02-21, disclosed to the SEC on 2025-02-21.
Scheduled sale ($5k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |